OpiSafe is a pioneering platform dedicated to addressing the opioid crisis through comprehensive data collection and analysis. The company serves healthcare providers, government agencies, and addiction prescribers by offering a suite of tools designed to monitor and manage opioid prescriptions and patient outcomes. Operating in the healthcare technology market, OpiSafe's business model revolves around subscription-based services and partnerships with government entities. The platform's core features include risk stratification based on Morphine Equivalent dosing ranges, withdrawal symptoms scores, behavioral health scores, and automated Prescription Drug Monitoring Program (PDMP) checks. Additionally, OpiSafe offers solutions for managing lab results, tracking comorbidities, and increasing reimbursements for healthcare providers. The company also provides OpiRescue HQ, a specialized tool for government agencies to track overdose events and distribute Naloxone, a medication used to reverse opioid overdoses. By integrating these tools into an easy-to-use web-based system, OpiSafe helps agencies comply with Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines. OpiSafe generates revenue through subscription fees, government contracts, and potential savings on malpractice insurance for its users.

Keywords: opioid crisis, risk stratification, patient engagement, PDMP checks, healthcare technology, addiction prescribers, government agencies, overdose tracking, Naloxone distribution, SAMHSA compliance.